A racing heart post‐Pfizer/<scp>BioNTech BNT162b2</scp>

Teo, Hooi Khee; Ho, Kah Leng; Tan, Boon Yew; Ching, Chi Keong; Chong, Daniel

doi:10.1002/joa3.12773

Cited by 5 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, our results showed a significant association between self-reported palpitations after the first vaccination and years of education. This may suggest that the patients with higher levels of education were more attentive to or better able to remember side effects such as palpitations, which have been previously reported for mRNA vaccines 86 , 87 . Another consideration for the results is that patients with SPMS tend to be older than patients with CIS or RRMS.…”

Section: Discussionsupporting

confidence: 58%

Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis

Burian,

Heidler,

Frahm

et al. 2024

Sci Rep

View full text Add to dashboard Cite

The recent SARS-CoV-2 pandemic and the vaccination campaign posed a challenge to patients with autoimmune disease, such as multiple sclerosis (MS). We aimed for investigating whether psychological/sociodemographic/clinical characteristics of MS patients are associated with SARS-CoV-2 vaccination status and self-reported vaccination side effects (SEs). We have asked patients with MS about their willingness to receive recommended standard vaccinations pre-pandemically since June 2019. Between 10/2021 and 01/2022, we surveyed 193 of these MS patients about their current SARS-CoV-2 vaccination status, their perception of vaccination-related SEs, and reasons for and against SARS-CoV-2 vaccination. 75.6% of the patients declared their willingness to receive standard vaccinations before the pandemic. 84.5%, 78.2%, and 13.0% of the patients had received the first, second, and third SARS-CoV-2 vaccination, respectively, until the follow-up survey. The most common reason for not getting vaccinated against SARS-CoV-2 was concern about possible side effects (82.1%), followed by the belief that the vaccines had not been adequately tested (64.3%). Vaccination-related SEs were reported by 52.8% of the patients. Younger age, higher education, lower degree of disability, relapsing disease course, shorter disease duration, not receiving a disease-modifying therapy and higher anxiety and depression levels were associated with the occurrence of certain vaccination-related SEs. Concerns about novel vaccines are widespread among MS patients and necessitate targeted education of the patients, especially to those with more severe psychopathological symptoms (anxiety or depression) and those who are generally skeptical of vaccination.

show abstract

Section: Discussionsupporting

confidence: 58%

Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis

Burian,

Heidler,

Frahm

et al. 2024

Sci Rep

View full text Add to dashboard Cite

show abstract

“…Autonomic dysfunction has been reported following infection with COVID-19 [3,4]. Additionally, there have been a few case reports of dysautonomia occurring in patients following vaccination, including postural orthostatic tachycardia syndrome (POTS) and a case of inappropriate sinus tachycardia (IST) [5][6][7][8][9].…”

Section: Introductionmentioning

confidence: 99%

Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome

Maharaj¹,

Swarath²,

Seecheran³

et al. 2023

Cureus

View full text Add to dashboard Cite

We present a case of a 15-year-old South Asian male who developed suspected postural orthostatic tachycardia syndrome (POTS) two weeks after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine booster, which was successfully managed with low-dose fludrocortisone and ivabradine. Clinicians should be aware of the Pfizer-BioNTech COVID-19 vaccine being implicated with the onset of POTS.

show abstract